HER-2-negative breast cancer

March 13, 2020March 13, 2020

Platinum Chemo No Better than Standard in BRCA-mutated Early BC, Trial Finds

News

Women with newly diagnosed breast cancer who carry a mutation in their BRCA genes may continue to receive the standard pre-surgery chemotherapy regimen used for other breast cancer patients, according ... Read more

December 17, 2014December 17, 2014

Sudy Finds Oncotype DX Diagnostic Reduces Chemotherapy Use In Young Breast Cancer Patients

News

Researchers at the University of Texas MD Anderson Cancer have conducted a large population-based study of Oncotype DX, finding it was significantly linked to a reduced use of chemotherapy in ... Read more

September 12, 2014September 12, 2014

First Nintedanib Clinical Trial For Breast Cancer From CNIO is Successful

Breast Cancer News, News

Positive results from the Spanish National Cancer Research Centre (CNIO)’s first Phase 1 clinical trial of nintedanib may advance the therapeutic forward in studies to treat HER-2-negative breast cancer. A ... Read more